Method for prejudging risk of liver cirrhosis patient suffering from liver cancer
A technology for patients and liver cancer, used in biological testing, material inspection products, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0055] Example 1 Establishing Risk Index
[0056] The medical staff divided 193 patients with liver cirrhosis participating in the experiment of the present invention into two groups according to the results of the health check. The first cohort included 161 patients with hepatitis B who had never had liver cancer (labeled "non-hepatic cancer cohort"). The second cohort consisted of 32 patients with hepatitis B who had suffered from early-stage liver cancer and were cured after receiving clinical treatment (labeled "liver cancer cohort"). However, within one year after the grouping, 5 patients who originally belonged to the non-liver cancer group developed liver cancer one after another. After regrouping the 5 patients, the liver cancer group contained 37 patients, while the non-liver cancer group contained 156 patients. According to the baseline demographic data shown in Table 1, no significant differences existed between the HCC group and the non-HCC group.
[0057] Table...
Embodiment 2
[0082] Embodiment 2 verifies the risk index of embodiment 1
[0083] Using the formula established in Example 1 to calculate the risk index of 183 liver cirrhosis patients, and group them according to their risk index; wherein 85 patients belong to the low-risk group, and 38 patients belong to the moderate-risk group, The 60 patients belong to the high-risk group. These patients were followed for 1.5 years. During the observation period, no one in the low-risk group developed liver cancer, while three and seven patients in the intermediate-risk and high-risk groups were diagnosed with liver cancer, respectively. in accordance with figure 1 According to the cumulative risk curve shown, patients in the high-risk group are more likely to suffer from liver cancer than patients in the low- or medium-risk group, and there is a significant difference (p=0.0213).
[0084] In order to further confirm the accuracy of the method disclosed in this disclosure, a total of 344 patients (i...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com